{"id":53113,"date":"2019-02-08T10:32:20","date_gmt":"2019-02-08T15:32:20","guid":{"rendered":"https:\/\/www.fomatmedical.com\/?p=10451"},"modified":"2026-04-28T18:41:54","modified_gmt":"2026-04-29T01:41:54","slug":"crohns-disease-gut-microbiome","status":"publish","type":"post","link":"https:\/\/fomatmedical.com\/es\/blogs-updates\/crohns-disease-gut-microbiome\/","title":{"rendered":"El an\u00e1lisis del metagenoma ayuda a comprender el papel de las especies bacterianas en la enfermedad de Crohn"},"content":{"rendered":"<div class=\"panel-pane pane-views pane-non-featured-content-title-widget\">\n<div class=\"pane-content\">\n<div class=\"view view-non-featured-content-title-widget view-id-non_featured_content_title_widget view-display-id-block view-dom-id-c8b1e81ee004869b571b4ca248f68a6e\">\n<div class=\"view-content\">\n<div class=\"views-row views-row-1 views-row-odd views-row-first views-row-last\">\n<div class=\"views-field views-field-title\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"panel-pane pane-entity-field pane-node-field-body-paragraphs\">\n<div class=\"pane-content\">\n<div class=\"paragraphs-items paragraphs-items-field-body-paragraphs paragraphs-items-field-body-paragraphs-full paragraphs-items-full\">\n<div class=\"field field-name-field-body-paragraphs field-type-paragraphs field-label-hidden\">\n<div class=\"field-items\">\n<div class=\"field-item odd\">\n<div class=\"entity entity-paragraphs-item paragraphs-item-embedded-text\">\n<div class=\"content\">\n<div class=\"field field-name-field-embedded-text field-type-text-long field-label-hidden\">\n<div class=\"field-items\">\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Crohns Disease Gut Microbiome: What Metagenomic Research Reveals<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Research on the Crohns disease gut microbiome is helping scientists understand how bacterial composition influences the development and progression of this debilitating inflammatory condition. A study published in BMC Genomics analyzes the gut metagenome of patients with Crohns disease, elucidating how it influences the taxonomic and functional composition of intestinal microbiota.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Among the most common changes observed in the Crohns disease gut microbiome are a decrease in the diversity of beneficial microbes and an increased abundance of Escherichia coli and other inflammation associated species. These results can help better understand the causes and progression of the disease, as well as optimize treatment approaches.<\/p>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">What Is Crohns Disease?<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Crohns disease is a severe inflammatory bowel disease that is widely prevalent in developed countries. Among its possible causal factors are genetic predisposition, environment, and patients&#8217; lifestyle. The disease is associated with an abnormal reaction of the immune system to a person&#8217;s own gut microbes \u2014 a condition known as gut dysbiosis.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The Crohns disease gut microbiome has become a central focus of research because studying the role of bacteria in the pathological process offers a pathway toward more effective diagnostics and treatment.<\/p>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">What Is Metagenomic Analysis?<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Among the most promising approaches to studying the Crohns disease gut microbiome is metagenomic analysis \u2014 the sequencing of total genetic material from a microbial community. A research team including scientists from ITMO University and specialists from the Federal Research and Clinical Center of Physical Chemical Medicine, in collaboration with clinicians from several medical centers, investigated the gut metagenome of patients with Crohns disease.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The researchers discovered that the composition of microbiota in patients with Crohns disease is significantly different compared to that of healthy subjects. As the fraction of normal microbes decreases, pathogenic species that are not prevalent in healthy people begin to dominate \u2014 a pattern consistently observed across the Crohns disease gut microbiome in multiple patient populations.<\/p>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Escherichia Coli and the Crohns Disease Gut Microbiome<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Although the type of dysbiosis varied from patient to patient, most manifested a several times increase in the abundance of Escherichia coli. The scientists set out to identify the specific genes that distinguish the subtypes of Escherichia coli inhabiting the gut of patients with Crohns disease from the common Escherichia coli found in healthy people.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The comparison conducted on the Russian population showed a lack of universal differences \u2014 an unexpected finding. These observations were confirmed during the analysis of publicly available datasets from healthy subjects and patients with Crohns disease from around the world.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Alexander Tyakht, a research associate at ITMO University, commented that the genetic content of Crohns disease associated Escherichia coli varies widely, despite the existing belief that only some specific varieties are involved. The results support the concept that Crohns disease is a syndrome \u2014 a disease in which similar manifestations across multiple cases are caused by different factors in each individual case.<\/p>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Multiple Strains and the Crohns Disease Gut Microbiome<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The research indicated that several strains of Escherichia coli can coexist in a human gut. Since strains with different genomes can play significantly different ecological roles, the same treatment schemes can have very different effects on different strains.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">This discovery offers an opportunity to improve the balance of the Crohns disease gut microbiome in patients, while personalized analysis of bacterial genotype offers an opportunity to select the most effective medications, probiotics, and even fecal mass transplantation donors for each individual patient.<\/p>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">What These Findings Mean for Treatment<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">These findings also resonate with earlier research involving genome analysis of isolated E. coli strains. The results shed light on how microbiota changes in patients with Crohns disease and which species and strains of bacteria participate in its development \u2014 ultimately helping to better understand the onset and progression of the disease and optimize treatment methods.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Understanding how research like this translates into new therapies requires understanding the clinical trial process. Our <a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/fomatmedical.com\/blogs-updates\/exploring-the-frontiers-of-medical-research-an-introduction-to-clinical-trials\/\">introduction to clinical trials<\/a> explains how discoveries move from metagenomic research into Phase I through Phase IV studies and ultimately into patient care.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">For those interested in how personalized data analysis is reshaping medicine more broadly, our article on <a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/fomatmedical.com\/blogs-updates\/technology-is-changing-the-face-of-drug-discovery-tissue-imaging-advancements\/\">personalized medicine drug discovery<\/a> explores how genomic, tissue, and biomarker data are being combined to develop more targeted therapies.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">According to the <a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/www.crohnscolitisfoundation.org\/what-is-crohns-disease\" target=\"_blank\" rel=\"noopener\">Crohns and Colitis Foundation<\/a>, approximately 780,000 Americans are currently living with Crohns disease \u2014 making advances in understanding the Crohns disease gut microbiome a critical priority for gastroenterology research.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Source: dddmag.com<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>El microbioma intestinal en la enfermedad de Crohn: lo que revela la investigaci\u00f3n metagen\u00f3mica La investigaci\u00f3n sobre el microbioma intestinal en la enfermedad de Crohn est\u00e1 ayudando a los cient\u00edficos a comprender c\u00f3mo la composici\u00f3n bacteriana influye en el desarrollo y la progresi\u00f3n de esta debilitante enfermedad inflamatoria. Un estudio publicado en BMC Genomics analiza el intestino\u2026<\/p>","protected":false},"author":3,"featured_media":93629,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[968,1205,984],"tags":[],"class_list":["post-53113","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blogs-updates","category-crohns-disease","category-research-studies"],"acf":[],"_links":{"self":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/53113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/comments?post=53113"}],"version-history":[{"count":3,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/53113\/revisions"}],"predecessor-version":[{"id":93559,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/53113\/revisions\/93559"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/media\/93629"}],"wp:attachment":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/media?parent=53113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/categories?post=53113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/tags?post=53113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}